{
  "id": 3760716,
  "title": "Lilly's move to hide Phase 1 pipeline draws mixed reviews",
  "url": "https://urgent.news/2026/08/27/lillys-move-to-hide-phase-1-pipeline-draws-mixed-reviews",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-27T15:02:11.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/lillys-move-to-hide-phase-1-pipeline-draws-mixed-reviews/"
  },
  "original_language": "en",
  "account": null,
  "summary": "As its world-leading GLP-1 earns more than any other medicine — and its market cap eclipses all other healthcare companies — Eli Lilly has decided to stop disclosing its Phase 1 pipeline. Lilly",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}